HCM
GCVRZ
Highbridge Capital Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-3,907,852
| Closed | -$4.62M | – | 102 |
|
2019
Q4 | $4.62M | Buy |
3,907,852
+47,598
| +1% | +$56.3K | 0.51% | 36 |
|
2019
Q3 | $2.18M | Buy |
3,860,254
+31,470
| +0.8% | +$17.7K | 0.32% | 32 |
|
2019
Q2 | $2M | Sell |
3,828,784
-5,779,569
| -60% | -$3.02M | 0.13% | 61 |
|
2019
Q1 | $4.33M | Buy |
9,608,353
+113,986
| +1% | +$51.4K | 0.13% | 121 |
|
2018
Q4 | $4.56M | Buy |
9,494,367
+593,486
| +7% | +$285K | 0.13% | 124 |
|
2018
Q3 | $4.69M | Buy |
8,900,881
+835,531
| +10% | +$440K | 0.11% | 168 |
|
2018
Q2 | $3.99M | Buy |
8,065,350
+651,755
| +9% | +$322K | 0.08% | 225 |
|
2018
Q1 | $3.11M | Buy |
7,413,595
+400,000
| +6% | +$168K | 0.05% | 297 |
|
2017
Q4 | $2.66M | Buy |
7,013,595
+2,497,879
| +55% | +$947K | 0.05% | 291 |
|
2017
Q3 | $1.6M | Buy |
4,515,716
+645,951
| +17% | +$229K | 0.02% | 374 |
|
2017
Q2 | $1.45M | Buy |
3,869,765
+559,890
| +17% | +$209K | 0.02% | 406 |
|
2017
Q1 | $1.44M | Buy |
3,309,875
+65,338
| +2% | +$28.4K | 0.02% | 443 |
|
2016
Q4 | $1.2M | Buy |
3,244,537
+2,216,137
| +215% | +$818K | 0.02% | 438 |
|
2016
Q3 | $278K | Buy |
+1,028,400
| New | +$278K | ﹤0.01% | 842 |
|
2013
Q4 | – | Sell |
-1,250,000
| Closed | -$2.53M | – | 1243 |
|
2013
Q3 | $2.53M | Sell |
1,250,000
-100,000
| -7% | -$202K | 0.03% | 415 |
|
2013
Q2 | $2.57M | Buy |
+1,350,000
| New | +$2.57M | 0.03% | 397 |
|